Clinical trials for NON RARE IN EUROPE: Non-alcoholic fatty liver disease
15 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 1NCT07335198A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Efimosfermin Alfa Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and White/European AncestryGlaxoSmithKline · PI: GSK Clinical Trials
- ACTIVE NOT RECRUITINGN/ANCT07366710Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PETRigshospitalet, Denmark
- RECRUITINGPhase 4NCT06449833Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLDZhujiang Hospital · PI: Hong Chen, MD
- RECRUITINGN/ANCT06413069Effects of Almonds in Glucose-intolerant Adults (AGAMEMNON)Charite University, Berlin, Germany
- RECRUITINGN/ANCT06275906Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
- RECRUITINGPhase 1NCT05979389Bicalutamide Therapy in Young Women With NAFLD and PCOSUniversity of California, San Francisco · PI: Monika A Sarkar, MD, MAS
- RECRUITINGN/ANCT06704321Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLDValbiotis · PI: André Marette, PhD
- ACTIVE NOT RECRUITINGN/ANCT06697977Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients with Nonalcoholic Fatty Liver DiseaseUniversity of Jordan
- RECRUITINGPhase 4NCT05644717Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLDGetz Pharma · PI: Umar Raja, MBBS
- RECRUITINGNCT05330923Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver DiseasePeking Union Medical College Hospital · PI: WEI Lyu
- ACTIVE NOT RECRUITINGN/ANCT04795219Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIVUniversity of California, San Francisco · PI: Jennifer Price, MD, PhD
- ACTIVE NOT RECRUITINGPhase 3NCT04951219A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)Madrigal Pharmaceuticals, Inc. · PI: Rebecca Taub, MD
- ACTIVE NOT RECRUITINGN/ANCT04999124Characteristics of NAFLD Among Type 2 Diabetes PatientsZiekenhuis Oost-Limburg · PI: Geert Robaeys, prof. dr.
- RECRUITINGNCT04442334The European NAFLD RegistryNewcastle University · PI: Quentin M Anstee, MBBS, PhD
- RECRUITINGN/ANCT03073343A Prospective, Randomized, Open Label Trial of Two Doses of Oral BetaineSouthern California Institute for Research and Education · PI: Timothy R Morgan, MD